BI Bets On Expanding Jardiance As Diabetes Drug Sales Soar

 
• By Kevin Grogan
Boehringer Ingelheim ARPC
BI board reviews a strong 2018 performance • Source: Boehringer Ingelheim

More from Business

More from Scrip